nolvadex dosage breast cancer

[Tutsstype]

After 10 years and 10, 000 women, the BCRF supported TAILORx trial confirms most women with early stage, ER positive breast cancer nearly 60, 000 women per year can forgo chemotherapy based on their Oncotype DX Recurrence Scores what does nolvadex do

[Autor]

Beiträge